Cited by 1,521Cancer-related Molecular PathwaysHeat shock proteins researchPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 65 of the 72 references it cites were found in a registry or an index.

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Open access

Pomerantz, Jason, Schreiber-Agus, Nicole, Liégeois, Nanette J, Silverman, Adam, Alland, Leila, Chin, Lynda, Potes, Jason, Chen, Ken, Orlow, Irene, Lee, Han-Woong, Cordon-Cardo, Carlos, DePinho, Ronald A·1998·Cell

DOI 10.1016/s0092-8674(00)81400-2

Open this paper in CoChat — free account Open PDF

Abstract

The INK4a gene encodes two distinct growth inhibitors--the cyclin-dependent kinase inhibitor p16Ink4a, which is a component of the Rb pathway, and the tumor suppressor p19Arf, which has been functionally linked to p53. Here we show that p19Arf potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19Arf and MDM2 physically interact and that p19Rrf blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19Arf functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)81400-2

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312

Show all 72 references

Research works printed but not linked: 6

Brenner, 1996, Preferential loss of expression of p16INK4a rather than p19ARF in breast cancer, Clin. Cancer Res., 2, 1993
Elledge, 1996, A question of balance, Trends Biochem. Sci., 6, 388
Kinoshita, 1996, Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer, Cancer Res., 56, 5557
Quelle, 1995, Cloning and characterization of murine p16INK4a and p15INK4b genes, Oncogene, 11, 635
Schreiber-Agus, 1994, Evolutionary relationships and functional conservation among vertebrate Max-associated proteins, Oncogene, 9, 3167
Schreiber-Agus, 1997, An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3, Cell, 80, 777, 10.1016/0092-8674(95)90356-9 · DOI

Sorted by citations

Items 901–1,000 of 1,001

Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis
Chambon, V., Vacher, M., Jullien, M., May, E., & Bourdon, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203960 · Cited by 28
Genetic dissection of melanoma pathways in the mouse
Yang, F. C., Merlino, G. T., & Chin, L. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0376 · Cited by 28
Self-citation
MDM2’s dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities
Gnanasundram, S. V., Malbert-Colas, L., Chen, S., Fusée, L. T. S., Daskalogianni, C., Müller, P., Salomao, N., & Fåhræus, R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa431 · Cited by 28
Regulation of p53 by E3s
Pan, M., & Blattner, C. (2021) · Cancers · doi:10.3390/cancers13040745 · Cited by 27
Cyclin‐dependent kinases as therapeutic targets in melanoma
Miller, D. M., & Flaherty, K. T. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12211 · Cited by 28
Potential Involvement of MYC- and p53-Related Pathways in Tumorigenesis in Human Oral Squamous Cell Carcinoma Revealed by Proteomic Analysis
Koehn, J., Krapfenbauer, K., Huber, S., Stein, E., Sutter, W., Watzinger, F., Erović, B. M., Thurnher, D., Schindler, T. H., Fountoulakis, M., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800077a · Cited by 27
Alternative product of the p16/CKDN2A locus connects the Rb and p53 tumor suppressors
James, M. C., & Peters, G. G. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4253-7_7 · Cited by 27
Deregulation of cell growth and malignant transformation.
Šulić, S., Panić, L., Đikić, I., & Volarević, S. (2005) · PubMed · Cited by 27
Astrocytic Tumors
Riemenschneider, M. J., & Reifenberger, G. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-31206-2_1 · Cited by 27
Deregulation of the Cell Cycle by the Epstein–Barr Virus
O’Nions, J., & Allday, M. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92006-4 · Cited by 28
Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status
Al‐Ayyoubi, S., & Gali‐Muhtasib, H. U. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20252 · Cited by 29
Abnormal Expression of Cell Cycle Regulatory Proteins in Ductal and Lobular Carcinomas of the Breast
Geradts, J., & Ingram, C. D. (2000) · Modern Pathology · doi:10.1038/modpathol.3880172 · Cited by 27
Monoclonal Antibodies to the Mouse p19 Arf Tumor Suppressor Protein
Bertwistle, D., Zindy, F., Sherr, C. J., & Roussel, M. F. (2004) · Hybridoma and Hybridomics · doi:10.1089/hyb.2004.23.293 · Cited by 27
The Tumor Suppressor ARF Regulates Innate Immune Responses in Mice
Través, P. G., López-Fontal, R., Luque, A., & Hortelano, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004070 · Cited by 27
MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development
Xie, X., Wang, X., Liao, W., Fei, R., Wu, N., Xu, C., Chen, Q., Wei, L., Wang, Y., & Chen, H. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0693-7 · Cited by 26
Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis
Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 26
Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke–related cholangiocarcinoma
Chinnasri, P., Pairojkul, C., Jearanaikoon, P., Sripa, B., Bhudhisawasdi, V., Tantimavanich, S., & Limpaiboon, T. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.11.002 · Cited by 26
Rapid asymmetric evolution of a dual-coding tumor suppressor INK4a/ARF locus contradicts its function
Szklarczyk, R., Heringa, J., Pond, S. L. K., & Nekrutenko, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703238104 · Cited by 26
ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation
Miao, L., Song, Z., Jin, L., Zhu, Y., Wen, L., & Wu, M. (2009) · Oncogene · doi:10.1038/onc.2009.372 · Cited by 26
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors
Yu, D., Carroll, M. P., & Thomas‐Tikhonenko, A. (2007) · Blood · doi:10.1182/blood-2006-10-050294 · Cited by 26
The promiscuity of ARF interactions with the proteasome
Pollice, A., Vivo, M., & Mantia, G. L. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.09.026 · Cited by 28
Integration of the PRB and P53 Cell Cycle Control Pathways
Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 27
Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting
D’Orazi, G., Marchetti, A., Crescenzi, M., Coen, S., Sacchi, A., & Soddu, S. (2000) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(200001/02)2:1 · Cited by 26
Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression
Phillips, D. C., Hunt, J. T., Moneypenny, C. G., MacLean, K. H., McKenzie, P., Harris, L. C., & Houghton, J. A. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402198 · Cited by 26
Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells
Thomas, S. L., Deadwyler, G., Tang, J. M., Stubbs, E. B., Muir, D., Hiatt, K. K., Clapp, D. W., & Vries, G. H. D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.159 · Cited by 29
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D’Amico, M., Wu, K., Vizio, D. D., Reutens, A. T., Stahl, M. C., Fu, M., Albanese, C., Russell, R. G., Muller, W. J., White, M. A., et al. (2003) · PubMed · Cited by 26
Self-citation
Human p14Arf: an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function
David-Pfeuty, T., & Nouvian-Dooghe, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205871 · Cited by 26
Inhibition of p63 Transcriptional Activity by p14ARF: Functional and Physical Link between Human ARF Tumor Suppressor and a Member of the p53 Family
Calabrò, V., Mansueto, G., Santoro, R., Gentilella, A., Pollice, A., Ghioni, P., Guerrini, L., & Mantia, G. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8529-8540.2004 · Cited by 26
Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens
Tokunaga, H., Shariat, S. F., Green, A. E., Brown, R. M., Zhou, J.-H., Benedict, W. F., & Lerner, S. P. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01586-3 · Cited by 26
Cdkn2a encodes functional variation of p16INK4a but not p14ARF, which confers selection in mouse lung tumorigenesis
Herzog, C. R., Noh, S. J., Lantry, L. E., Guan, K.-L., & You, M. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199906)25:2 · Cited by 26
UV but not gamma irradiation accelerates p53-induced apoptosis of teratocarcinoma cells by repressing MDM2 transcription.
Zeng, X., Keller, D., Wu, L., & Lu, H. (2000) · PubMed · Cited by 26
The DNA Damage Checkpoint and Human CancerPreprint
Schultz, L. B., Chehab, N. H., Malikzay, A., DiTullio, R. A., Stavridi, E. S., & Halazonetis, T. D. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.489 · Cited by 26
A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle
Li, H., Dong, L., Jin, M.-J., Li, Q.-Y., Wang, X. Q., Jia, M., Song, J., Zhang, S., & Yuan, S. (2023) · Molecules · doi:10.3390/molecules28031141 · Cited by 25
A role for the p53 pathway in the pathology of meningiomas with NF2 loss
Chang, Z., Guo, C., Ahronowitz, I. Z., Stemmer-Rachamimov, A. O., MacCollin, M., & Nunes, F. P. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9721-3 · Cited by 25
P14ARF: The Absence that Makes the Difference
Cilluffo, D., Barra, V., & Leonardo, A. D. (2020) · Genes · doi:10.3390/genes11070824 · Cited by 25
Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14ARF-Mediated Sustained p53 Activation
Tomicic, M. T., Krämer, F., Nguyen, A., Schwarzenbach, C., & Christmann, M. (2021) · Cancers · doi:10.3390/cancers13092019 · Cited by 28
Histopathology, pathogenesis and molecular genetics in primary central nervous system lymphomas.
Nakamura, M., Shimada, K., Ishida, E., & Konishi, N. (2004) · PubMed · doi:10.14670/hh-19.211 · Cited by 25
PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53
Zheng, G., Ning, J., & Yang, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.003 · Cited by 25
Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma
Isaacs, J. S., Saito, S., & Neckers, L. Μ. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100638200 · Cited by 25
Stress-associated hormone, norepinephrine, increases proliferation and IL-6 levels of human pancreatic duct epithelial cells and can be inhibited by the dietary agent, sulforaphane
Lin, J. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000023 · Cited by 25
Overproduction of MDM2 in vivo disrupts S phase independent of E2F1.
Reinke, V., Bortner, D. M., Amelse, L. L., Lundgren, K., Rosenberg, M. P., Finlay, C. A., & Lozano, G. (1999) · PubMed · Cited by 25
Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite
Chou, R., & Huang, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00212-7 · Cited by 25
Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma
Park, M.-J., Shimizu, K., 中野, 哲., Park, Y. B., Kohno, T., Tani, M., & Yokota, J. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00645-3 · Cited by 25
Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers
Grüttgen, A., Reichenzeller, M., Jünger, M., Schlien, S., Affolter, A., & Bosch, F. X. (2001) · The Journal of Pathology · doi:10.1002/path.906 · Cited by 25
Aberrations of the p14ARF and p16INK4a Genes in Renal Cell Carcinomas
Kawada, Y., Nakamura, M., Ishida, E., Shimada, K., Oosterwijk, E., Uemura, H., Hirao, Y., Chul, K. S., & Konishi, N. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02152.x · Cited by 25
The t(8;21) fusion protein contacts co-repressors and histone deacetylases to repress the transcription of the p14ARF tumor suppressor
Hiebert, S. W., Reed-Inderbitzin, E. F., Amann, J. M., Irvin, B. J., Durst, K. L., & Linggi, B. E. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00021-4 · Cited by 26
Growth Factors in Lens Development
Lang, R. A., & McAvoy, J. W. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.012 · Cited by 25
3-Morpholinosydnonimine Hydrochloride Induces p53-Dependent Apoptosis in Murine Primary Neural Cells: A Critical Role for p21ras–MAPK–p19ARF Pathway
Kaji, T., Kaieda, I., Hisatsune, T., & Kaminogawa, S. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0389 · Cited by 25
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Cosci, I., Salizzato, V., Fiore, P. D., Pigozzo, J., Guarneri, V., D, S. M. M., Ferlin, A., Mathlouthi, S., Piccin, L., & Garofalo, M. (2025) · Pharmaceuticals · doi:10.3390/ph18081235 · Cited by 26
Post-Translational Regulation of ARF: Perspective in Cancer
Seo, J., Seong, D., Lee, S. R., Oh, D., & Song, J. (2020) · Biomolecules · doi:10.3390/biom10081143 · Cited by 25
MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia
Boldrin, E., Gaffo, E., Niedermayer, A., Boer, J. M., Zimmermann, M., Weichenhan, D., Claus, R., Münch, V., Sun, Q., Enzenmüller, S., et al. (2021) · Blood · doi:10.1182/blood.2020007591 · Cited by 24
Collaborator of alternative reading frame protein (CARF) regulates early processing of pre-ribosomal RNA by retaining XRN2 (5′-3′ exoribonuclease) in the nucleoplasm
Sato, S., Ishikawa, H., Yoshikawa, H., Izumikawa, K., Simpson, R. J., & Takahashi, N. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1069 · Cited by 24
A highly sensitive fluorescent light-up probe for real-time detection of the endogenous protein target and its antagonism in live cells
Geng, J., Goh, W. L., Zhang, C., Lane, D. P., Liu, B., Ghadessy, F. J., & Tan, Y. N. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00819k · Cited by 24
The cellular abundance of the essential transcription termination factor TTF-I regulates ribosome biogenesis and is determined by MDM2 ubiquitinylation
Lessard, F., Stefanovsky, V. Y., Tremblay, M. G., & Moss, T. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks198 · Cited by 27
NMI mediates transcription-independent ARF regulation in response to cellular stresses
Li, Z., Hou, J., Sun, L., Wen, T., Wang, L., Zhao, X., Xie, Q., & Zhang, S. Q. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-04-0304 · Cited by 25
The p27 Pathway Modulates the Regulation of Skeletal Growth and Osteoblastic Bone Formation by Parathyroid Hormone–Related Peptide
Zhu, M., Zhang, J., Zhan, D., Zhang, Y., Wang, R., Karaplis, A. C., Goltzman, D., & Miao, D. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2544 · Cited by 24
Genetic Alterations of the p14ARF-hdm2-p53 Regulatory Pathway in Breast Carcinoma
Ho, G. H., Calvano, J. E., Bisogna, M., Abouezzi, Z. E., Borgen, P. I., Cordon‐Cardo, C., & Zee, K. J. V. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010686518990 · Cited by 24
Self-citation
Molecular markers in bladder cancer
Hussain, S. A., & James, N. D. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.07.007 · Cited by 24
A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression
Zhang, Z., Wang, Y., Herzog, C. R., Liu, G., Lee, H., DePinho, R. A., & You, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205725 · Cited by 24
Self-citation
p53 in breast cancer: mutation and countermeasures
Kumar, S. R. (2007) · Frontiers in bioscience · doi:10.2741/2378 · Cited by 24
Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen
Xu, L., Flynn, B. J., Ungar, S., Pass, H. I., Linnainmaa, K., Mattson, K. V., & Gerwin, B. I. (1999) · Carcinogenesis · doi:10.1093/carcin/20.5.773 · Cited by 24
Loss of p19 ARF Eliminates the Requirement for the pRB-Binding Motif in Simian Virus 40 Large T Antigen-Mediated Transformation
Chao, H. H., Buchmann, A. M., & DeCaprio, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7624-7633.2000 · Cited by 25
Dissociation of Bone Morphogenetic Protein-Mediated Growth Arrest and Apoptosis of Mouse B Cells by HPV-16 E6/E7
Yamato, K., Hashimoto, S., Okahashi, N., Ishisaki, A., Nonaka, K., Koseki, T., Kizaki, M., Ikeda, Y., & Nishihara, T. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4876 · Cited by 24
Identification of Senescence-Associated Genes and Their Networks Under Oxidative Stress by the Analysis of Bach1
Ota, K., Dohi, Y., Brydun, A., Nakanome, A., Ito, S., & Igarashi, K. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3574 · Cited by 23
Epstein-Barr Virus Nuclear Antigen 3A Promotes Cellular Proliferation by Repression of the Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1
Tursiella, M. L., Bowman, E., Wanzeck, K. C., Throm, R. E., Liao, J., Zhu, J., & Sample, C. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004415 · Cited by 23
Human p53 knock-in ( hupki ) mice do not differ in liver tumor response from their counterparts with murine p53
Jaworski, M., Hailfinger, S., Buchmann, A., Hergenhahn, M., Hollstein, M., Ittrich, C., & Schwarz, M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi142 · Cited by 23
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma
Catani, J. P. P., Medrano, R. F. V., Hunger, A., Valle, P. R. D., Adjemian, S., Zanatta, D. B., Kroemer, G., Costanzi-Strauss, E., & Strauss, B. E. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.09.011 · Cited by 24
CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer
Pan, Q., Sathe, A., Black, P. C., Goebell, P. J., Kamat, A. M., Schmitz‐Dräger, B. J., & Nawroth, R. (2017) · Bladder Cancer · doi:10.3233/blc-170105 · Cited by 24
Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy
Aleotti, V., Catoni, C., Poggiana, C., Rosato, A., Facchinetti, A., & Scaini, M. C. (2021) · Cancers · doi:10.3390/cancers13246217 · Cited by 23
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Jiang, H., Luo, J., & Lei, H. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2021.108910 · Cited by 23
JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity
Yang, M., Wu, S., Su, X., & May, W. S. (2006) · Blood · doi:10.1182/blood-2006-06-029645 · Cited by 23
Physical and Functional Interaction of the p14ARF Tumor Suppressor with Ribosomes
Rizos, H., McKenzie, H. A., Ayub, A. L. P., Woodruff, S., Becker, T. M., Scurr, L. L., Stahl, J., & Kefford, R. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609405200 · Cited by 23
Caspase-9 can antagonize p53-induced apoptosis by generating a p76Rb truncated form of Rb
Lemaire, C., Godefroy, N., Ferecatu, I., Rincheval, V., Renaud, F., Trotot, P. K., Bouleau, S., Mignotte, B., & Vayssière, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208493 · Cited by 23
Isolation of immortalized, INK4a/ARF-deficient cells from the subventricular zone after in utero N-ethyl-N-nitrosourea exposure
Savarese, T. M., Jang, T., Low, H. P., Salmonsen, R. A., Litofsky, N. S., Matijašević, Z., Ross, A. H., & Recht, L. D. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.1.0098 · Cited by 23
The MDM2 Oncoprotein Promotes Apoptosis in p53-Deficient Human Medullary Thyroid Carcinoma Cells
Dilla, T., Velasco, J. A., Medina, D. L., Jf, G.-P., & Santisteban, P. (2000) · Endocrinology · doi:10.1210/endo.141.1.7265 · Cited by 23
p16INK4A(CDKN2A) Gene Deletion Is a Frequent Genetic Event in Synovial Sarcomas
Subramaniam, M. M., Noguera, R., Piqueras, M., Navarro, S., López‐Guerrero, J. A., & Llombart‐Bosch, A. (2006) · American Journal of Clinical Pathology · doi:10.1309/e2aay2xxn431wl81 · Cited by 23
Lens Crystallins
Duncan, M. K., Cvekl, A., Kantorow, M., & Piatigorsky, J. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.006 · Cited by 23
Analysis of TP53 Mutations in Relapsed Childhood Acute Lymphoblastic Leukemia
Gump, J. M., McGavran, L., Wei, Q., & Hunger, S. P. (2001) · The American journal of pediatric hematology/oncology · doi:10.1097/00043426-200110000-00005 · Cited by 23
Bmi-1-shRNA Inhibits the Proliferation of Lung Adenocarcinoma Cells by Blocking the G1/S Phase Through Decreasing Cyclin D1 and Increasing p21/p27 Levels
Zheng, X., Wang, Y.-F., Liu, B., Liu, C., Liu, D., Zhu, J., Yang, C., Yan, J., Liao, X., Meng, X., et al. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0459 · Cited by 22
Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung
Xue, Q., Sano, T., Kashiwabara, K., Saitō, M., Oyama, T., & Nakajima, T. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01321.x · Cited by 22
Global Gene Expression Profiling of Hyperkeratotic Skin Lesions from Inner Mongolians Chronically Exposed to Arsenic
Bailey, K. A., Xia, Y., Ward, W. O., Knapp, G. W., Mo, J., Mumford, J. L., Owen, R. D., & Thai, S. (2009) · Toxicologic Pathology · doi:10.1177/0192623309351725 · Cited by 22
p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells
Harajly, M., Zalzali, H., Nawaz, Z., Ghayad, S. E., Ghamloush, F., Basma, H., Zainedin, S., Rabeh, W., Jabbour, M. N., Tawil, A. N., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00747-15 · Cited by 24
p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
Divan, A., Lawry, J., DUNSMORE, I. R., Parsons, M. A., & Royds, J. A. (2001) · PubMed · Cited by 22
Epoxy clerodane diterpene inhibits MCF-7 human breast cancer cell growth by regulating the expression of the functional apoptotic genes Cdkn2A, Rb1, mdm2 and p53
Subash‐Babu, P., Alshammari, G. M., Savarimuthu Ignacimuthu, S. J., & Alshatwi, A. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.091 · Cited by 22
Hepatitis B virus X protein activates E3 ubiquitin ligase Siah-1 to control virus propagation via a negative feedback loop
Yeom, S., Kim, S. S., Jeong, H., & Jang, K. L. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000856 · Cited by 22
Disruption of Scaffold Attachment Factor B1 Leads to TBX2 Up-regulation, Lack of p19ARF Induction, Lack of Senescence, and Cell Immortalization
Dobrzycka, K. M., Kang, K., Jiang, S., Meyer, R., Rao, P. H., Lee, A. V., & Oesterreich, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1381 · Cited by 23
Liver-directed viral therapy for cancer
Warren, R. S., & Kirn, D. H. (2002) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00043-1 · Cited by 22
Lens Induction and Determination
Fisher, M. A., & Grainger, R. M. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.003 · Cited by 22
Cell Cycle Checkpoint Genes and Cancer
Funk, J. O. (2006) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0006046 · Cited by 22
The cell cycle regulator p16 promotes tumor infiltrated CD8+ T cell exhaustion and apoptosis
Zhang, X., Wang, J., Tang, K., Yang, Y., Liu, X., Yuan, S., Guo, F., Zhang, L., & Ma, K. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06721-7 · Cited by 21
p15Ink4b Functions in determining hematopoietic cell fates: Implications for its role as a tumor suppressor
Wolff, L., & Bies, J. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.01.006 · Cited by 21
Cell fate conversion: Direct induction of hepatocyte‐like cells from fibroblasts
Ji, S., Zhang, L., & Hui, L. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24380 · Cited by 21
Prognostication of Vulvar Cancer Based on p14ARF Status: Molecular Assessment of Transcript and Protein
Lavorato-Rocha, A. M., Maia, B. D. M., Rodrigues, I. S., Stiepcich, M. M., Baiocchi, G., Cestari, F. M., Carvalho, K. C., Soares, F. A., & Rocha, R. M. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2560-7 · Cited by 21
p16 Controls p53 Protein Expression Through miR-dependent Destabilization of MDM2
Al‐Khalaf, H. H., & Aboussekhra, A. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0017 · Cited by 22
The inv(16) Cooperates with ARF Haploinsufficiency to Induce Acute Myeloid Leukemia
Moreno–Miralles, I., Pan, L., Keates‐Baleeiro, J., Goodwin, K. D., Yang, C., Kim, H., Thompson, M. A., Klug, C. A., Cleveland, J. L., & Hiebert, S. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506855200 · Cited by 21
Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas
Bisogna, M., Calvano, J. E., Ho, G. H., Orlow, I., Cordon‐Cardo, C., Borgen, P. I., & Zee, K. J. V. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00367-8 · Cited by 21
Self-citation
Lens Fiber Differentiation
Bassnett, S., & Beebe, D. C. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.010 · Cited by 21
The Genes and Genetics of Malignant Melanoma
Gibbs, P., Brady, B., & Robinson, W. A. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-001-0037-6 · Cited by 21
Integration of DNA damage and repair with murine double-minute 2 (Mdm2) in tumorigenesis
Lehman, J., & Mayo, L. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131216373 · Cited by 9
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1

Authors: Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., Cordon-Cardo, C., & DePinho, R. A.
Affiliations: Albert Einstein College of Medicine (US)
Memorial Sloan Kettering Cancer Center (US)
Corresponding author: DePinho, Ronald A
ORCID: Pomerantz, Jason
Liégeois, Nanette J
Chen, Ken
Orlow, Irene
Lee, Han-Woong
DePinho, Ronald A
Venue: Cell
Publisher: Elsevier BV
Published: 1998-03
Volume: 92
Issue: 6
Pages: 713-723
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)81400-2
OpenAlex: W2039463309
Cited by: 1,521
References: 72
Citations by year: 2026: 4 · 2025: 10 · 2024: 6 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 19 · 2019: 16 · 2018: 12 · 2017: 24 · 2016: 27 · 2015: 32 · 2014: 44 · 2013: 44 · 2012: 47
FWCI: 64.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5617 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 47179, CA 47538, CADK97650, P01CA047179)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: p19ARF, INK4A, MDM2, p53, tumor suppression, protein-protein interaction, p53 degradation, p53 transactivation, oncogenic transformation, Rb pathway, viral oncoproteins, dominant-negative mutant
MeSH terms: Animals, Biotin, Cell Line, Deoxyuracil Nucleotides, Lens, Crystalline, Neoplasm Proteins, Nuclear Proteins, Osteoblasts, Proteins, Proto-Oncogene Proteins, Staining and Labeling, Transformation, Genetic, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Genes, p16, Tumor Suppressor Protein p14ARF, Mice, Proto-Oncogene Proteins c-mdm2, DNA Fragmentation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks